期刊文献+

法舒地尔对急性冠状动脉综合征患者血管内皮功能的影响 被引量:3

Effect of fasudil on endothelial function in patients with acute coronary syndrome
原文传递
导出
摘要 目的 研究法舒地尔对急性冠状动脉综合征(以下简称急性冠脉综合征)患者血管内皮功能的影响.方法 随机选择急性冠脉综合征患者80例,将入选患者按随机单盲法分为法舒地尔治疗组40例,常规治疗组40例,另外随机选择40例正常人做对照组.分别测定两组治疗前及治疗后4周血浆内皮素、一氧化氮含量.结果 急性冠脉综合征患者血浆一氧化氮水平明显下降,与对照组比较差异有统计学意义(P<0.01);血浆内皮素水平明显升高,与对照组比较差异有统计学意义(P<0.01);急性冠脉综合征组和常规治疗组两组治疗前血浆内皮素、一氧化氮水平比较差异无统计学意义(P>0.05).急性冠脉综合征组治疗后一氧化氮水平较前明显升高, 血浆内皮素水平较前明显降低,与治疗前比较差异有统计学意义(P<0.01),与常规治疗组治疗后比较差异亦有统计学意义(P<0.05).结论 法舒地尔对急性冠脉综合征患者具有保护血管内皮功能的作用. Objective To explore the effect of fasudil on vascular endothelial function in patients with acute coronary syndrome.Methods Randomly selected patients with acute coronary syndrome in 80 cases, all patients were selected randomly divided into single-blind fasudil group of 40 patients, 40 patients with conventional treatment group, and randomly selected 40 cases of normal people to the control group. The two groups were measured before and after treatment for 2 weeks ET, nitric oxide.Results Acute coronary syndrome patients with decreased levels of nitric oxide, there was a significant difference compared with the control group (P<0.01).Plasma ET levels were significantly increased compared with the control group,and there was a significant difference (P<0.01).ET, nitric oxide levels were not significantly different between the two groups before treatment (P>0.05). The level of nitric oxide significantly increased, plasma ET levels significantly decreased than that before treatment and the difference was significant (P<0.01), and compared with the conventional treatment group, the difference was also significant (P<0.05).Conclusions Fasudil on patients with acute coronary syndrome has the protection of vascular endothelial function.
出处 《中国实用医刊》 2010年第18期19-21,共3页 Chinese Journal of Practical Medicine
关键词 法舒地尔 急性冠状动脉综合征 内皮素 一氧化氮 Fasudil Acute coronary syndrome Endothelin Nitric oxide
  • 相关文献

同被引文献19

  • 1陈颖,徐培敬,张枫林.冠心病患者血小板活化因子(CD62p、CD63)表达的临床意义[J].中国心血管病研究,2007,5(2):112-113. 被引量:8
  • 2陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 3中华医学会心血管病分会 中华心血管杂志编辑委员会.不稳定型心绞痛诊断和治疗建议.中华心血管病杂志,2000,:4209-4212.
  • 4Yaziei M, Demircan S, Duma K, el al. Relationship be- tween Myocardial Injury and Soluble p-seleetin in Non- ST Elevation [J]. Acnte Coronary Syndromes,2005,69 (5) :530-535.
  • 5叶登菊 任燕怡.阿托伐他汀钙对急性冠脉综合征患者内皮功能的影响.中国健康月刊,2010,29(6):20-21.
  • 6全国中西医结合防治及心律失常研究座谈会.冠心病心绞痛及心电图疗效标准.中医杂志,1996,37(10):583-583.
  • 7Wettwchureck N, Offermanns S. Rho - kinase mediated signaling in physiology and pathopaysiology[J]. J Mol Med, 2002,80 629 - 638.
  • 8Otsuka T,Ibuki C,Suzuki T,et al. Administration of the Rho- ki- nase inhibitor Fasudil to wing nitroglycerin additionally dilates the site ocoronary spasmin patients with vasospastie angina[J]. Coro- nary Artery disease, 2008,19 : 105 - 110.
  • 9Shmokawa H, Rashd M. Development of Rho - kinase inhibitors for cardiovascular medicine [J]. Trends Pharmacol Sci, 2007,28 (6) :296 - 302.
  • 10马倩,操乐杰.循环内皮细胞的研究新进展[J].实用临床医药杂志,2008,12(7):8-11. 被引量:2

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部